Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002163909 | SCV002474429 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-07-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003883790 | SCV004699681 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CACNA1A: BP4, BP7 |
Prevention |
RCV003985551 | SCV004736489 | likely benign | CACNA1A-related disorder | 2023-01-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV003883790 | SCV005209547 | likely benign | not provided | criteria provided, single submitter | not provided |